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Psoriasis is a chronic inﬂammatory skin disease with overlapping subphenotypes. It has a strong complex genetic
component, but has been problematic to identifying signiﬁcant loci. We evaluated 1000 patients with chronic
plaque psoriasis and documented several subphenotypes. Here we report results of genome-wide linkage scans for
psoriasis genes in 238 Icelandic families with 874 patients. MHC linkage was conﬁrmed with LOD score of 10.9.
When the entire cohort was analyzed, two other loci with LOD scores of 2.5 and 1.5 were observed on 16q and 4q,
respectively. Stratiﬁcation into subphenotypes revealed additional loci with LOD scores exceeding or approaching
significance. A LOD score of 5.7 appeared on 16q in PsA patients with analysis conditioned on parental inheritance.
A LOD score of 3.6 on 4q was detected when disease occurred at or older than 17 y, our median cohort age. This
locus was deﬁned by a marker near one reportedly displaying significant linkage in a Chinese psoriasis population
and near suggestive linkage in a Caucasian population. A LOD of 3.0 was observed on 10q when disease onset
occurred in the scalp. Furthermore, clinical stratiﬁcation either revealed or increased LOD scores when compared
to unstratiﬁed analysis and some coincided with previous reports.
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Psoriasis [MIM177900] is a chronic inflammatory and
hyperkeratotic skin disease that is believed to be mediat-
ed by T lymphocytes (Baker et al, 1984; Valdimarsson et al,
1986; Prinz, 1999). The etiology of psoriasis is unknown but
it has a strong genetic component (Farber and Nall, 1974;
Elder et al, 1994). Several distinct but overlapping subphe-
notypes of the disease have been identified, including
chronic plaques that are the most common form, sebopso-
riasis-type lesions, guttate eruptions, pustular lesions, and
the rare but severe erythrodermic form. Although these dif-
ferent phenotypes may all converge on a common patho-
genic pathway, they probably have somewhat different
genetic backgrounds. Previous studies have shown possi-
ble linkage to many loci, including the major histocompat-
ibility molecules (MHC) as well as loci on chromosomes 1q,
1p, 2p, 3q, 4q, 8q, 10q,16q, 17q, 18p, 19p, and 20p (Tom-
fohrde et al, 1994; Matthews et al, 1996; Nair et al, 1997;
Trembath et al, 1997; Burden et al, 1998; Jenisch et al,
1998; Capon et al, 1999; Enlund et al, 1999a, b; Lee et al,
2000; Veal et al, 2001; Asumalahti et al, 2003). A recent
study was conducted by an international consortium on the
genetics of psoriasis that combined patient material from
three groups studying the genetics of psoriasis. They found
linkage and association of statistical significance only at the
MHC (International Psoriasis Genetics Consortium, 2003).
Some groups that have detected significant loci in genomic
regions other than the MHC have launched fine mapping
projects, aimed at locating regions of association signifying
proximity to a contributing gene (Capon et al, 2001; Hewett
et al, 2002). At least two groups have located candidate
genes outside the MHC: one, named SLC12A8, is homol-
ogous to a cotransporter family, was found in a Swedish
population (Hewett et al, 2002) and an RUNX1 binding site
variant also near a transporter gene (SLC9A31), associated
with psoriasis (Helms et al, 2003) in a region previously de-
scribed as containing an interesting immunoglobulin super-
family gene cluster in the middle of their area of linkage on
17q (Speckman et al, 2003). RUNX1 binding sites have
previously been associated with auto-immune diseases
such as rheumatoid arthritis (RA) and systemic lupus ery-
thematosus (Prokunina et al, 2002; Tokuhiro et al, 2003). But
only the MHC locus has met accepted criteria for genome-
wide significance and been consistently replicated in inde-
pendent studies (Elder et al, 2001). Additionally, many stud-
ies have reported an association between psoriasis and
alleles in the MHC, particularly human leukocyte antigen
(HLA)-Cw0602 (Jenisch et al, 1998; Balendran et al, 1999;
Oka et al, 1999; Nair et al, 2000). Estimates of the carrier
frequency of this allele in Caucasian populations are around
15% whereas in psoriasis patients it ranges between 55%
and 80%, leading to risk ratios between 4 and 15 (Tiilikainen
et al, 1980; Mallon et al, 1999). Other genes within HLA class
III/I have also been implicated in several studies (Ishihara
et al, 1996; Jenisch et al, 1999; Tazi Ahnini et al, 1999; As-
umalahti et al, 2000, 2002; Schmitt-Egenolf et al, 2001; Orru
Abbreviations: MHC, major histocompatibility molecules; LOD,
logarithm of odds ratio; HLA, human leukocyte antigen; POPP,
pediatric onset psoriatic patients; AOPP, adult onset psoriatic
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et al, 2002), although these findings have not been confirmed
by others (Enerback et al, 2000; Chia et al, 2001; O’Brien
et al, 2001), and no group has been able to identify a single
allele as tightly associated with psoriasis as HLA-Cw6. Clear-
ly, HLA-Cw0602 allele, or an allele close to HLA-C, contrib-
utes strongly to predisposition to psoriasis. Nonetheless, the
MHC association explains only a portion of the genetic con-
tribution to psoriasis and the remaining genetic factors are
largely unknown and may vary between populations.
Confirmation of non-MHC loci between populations is
rare and, a confirmation linkage has never reached the cri-
teria for independent genome-wide significance although
several have reached the confirmation criteria of logarithm
of odds ratio (LOD) 2 (Nair et al, 1997; Enlund et al, 1999;
Karason et al, 2003). It seems that despite the almost uni-
versally observed association with HLA-Cw6, genetic stud-
ies of psoriasis have been difficult as have genetic studies
of other complex diseases. We and others have failed to
observe increases in the LOD scores of suggestive loci
outside the MHC region by increasing cohort size. The rea-
sons for this may include locus heterogeneity, epistasis, and
dynamic mutations. Furthermore, twin studies indicate that
age at onset and various other differences in the clinical
features of psoriasis are determined by genetic factors
(Farber and Nall, 1974; Brandrup et al, 1982), and it may be
difficult to identify such subphenotypic components when
patients’ cohorts are analyzed as a single clinical entity.
Stratification of patients using clinical phenotypes might
help to localize predisposing genes, and we have already
reported a significant linkage to the arthritic phenotype
of psoriasis that was not detected when our psoriasis co-
hort was analyzed as a homogenous group (Karason et al,
2003). As we have carefully evaluated the medical history
and a standardized set of clinical features for all patients in
our cohort, it was decided to use other phenotypic features
for further genetic analysis of patients. In this way, an in-
crease in LOD score was observed at several loci that had
previously shown a modest linkage to psoriasis, including
one narrowly missing independent genome-wide signifi-
cance.
Results
The broad psoriasis phenotype Using the genealogy da-
tabase, 874 patients were clustered into 238 families with
up to and including six meioses. Without clinical stratifica-
tion of patients, the results showed a highly significant link-
age to the MHC region on chromosome 6p21.3 with an LOD
score of 10.9 at marker TNFA (Fig 1) Chromosome 16q
showed suggestive linkage with an LOD score of 2.5 at
around 84 cM where we have a genome-wide significant
locus for psoriatic arthritis, and several groups have report-
ed suggestive linkage (Nair et al, 1997; Karason et al, 2003),
and a modest LOD score of 1.5 was observed on chromo-
some 4q (Fig 2) (marker DG4S106). A scan of female
psoriasis patients yielded an LOD score of 2.6 on the q
arm of chromosome 5 at D5S2090 (Fig 3), which maps
within 17 Mb of the RUNX1 binding site associated with RA.
No other suggestive linkage was observed in the unstrat-
ified cohort.
We also confirmed previously reported allelic association
between HLA-Cw0602 and psoriasis. Sixty-four percent of
patients (643/997) were carriers of Cw6 compared with
15%, (79/505) of controls, giving an estimated risk ratio of
9.8 for Cw6 carriers versus non-carriers. Our data are con-
sistent with the MHC risk allele being either HLA-Cw0602
itself or a risk variant located very close to HLA-C (data not
shown). Even though Cw6 carriers had a much higher risk of
developing psoriasis than non-carriers, we estimated the
penetrance of Cw6 at 10%, assuming that the population
risk of psoriasis is 2.5%.
To further explore the contribution of Cw6-associated
susceptibility, we divided patients into two groups based on
Cw6 carrier status and repeated the linkage analysis for
each group. When only patients who carry HLA-Cw6 were
classified as affected, the LOD score in the MHC region
predictably rose to 17 (Fig 3). Loci with LOD scores of sug-
gestive linkage (greater than 2.2) were found on 5p and 7q.
Conversely, we performed linkage analysis classifying only
the Cw6-negative patients as affected. An LOD score ap-
proaching 2 was seen on 1q (Fig 4). In addition, Cw6-
negative patients showed modest linkage on chromosome
17q (LOD score 1.5) at the location where Tomfohrde
et al found the first non-MHC locus in 1994 and where
the RUNX1 binding site is located (Helms et al, 2003)
(Fig 5), perhaps suggesting that the associated variant
segregates more frequently in families where Cw6 is not
prevalent.
Subphenotype analysis The MHC locus and the excess of
HLA-Cw6 are the only genetic findings that have consist-
ently been reported in psoriasis patients. It is unlikely, how-
ever, that a gene in the MHC locus is involved in the
pathogenesis in all psoriasis patients, because HLA-Cw6 is
only present in approximately 60% of patients. Patients with
chronic plaque psoriasis, however, show a marked clinical
heterogeneity, which is likely genetically determined (Brand-
rup et al, 1982), but is only to some extent associated with
the presence or absence of Cw6 (Gudjonsson et al, 2002).
We therefore decided to analyze genotypes in relation to
certain clinical subphenotypes of this disease.
Age at disease onset The age at onset ranged from 1–72 y
in our cohort with a median of 17 y. Seventeen years was
defined by Raychaudhuri and Gross (2000) as a cutoff point
for defining pediatric onset psoriatic patients (POPP) and
adult onset psoriatic patients (AOPP). Marked clinical dif-
ferences have been reported between these early- and late-
onset groups. Therefore, we decided to compare these two
groups in our genetic study. About 75% of the POPP group
carried Cw6 compared with 45% of the AOPP group. The
two groups were clustered into families using our genealogy
database at a maximum genetic distance of seven meioses.
This left us with 449 patients in 170 families for the POPP
group and 516 patients in 186 families for the AOPP group.
The combined number of families in the AOPP and POPP
groups (356) does not contradict the total number in the
unstratified scan (238) because clustering is performed on
each new phenotype and new and often smaller family
structures are expected. When linkage analysis was per-
formed on AOPP, an LOD score of 3.6 was observed
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Figure 1
The linkage result of 874 psoriasis patients in 238 families up to and including six meioses, genotyped with a 1000 marker genome-wide
microsatellite screening set showing a highly significant linkage to the major histocompatibility complex region on chromosome. 6p21.3
with a logarithm of odds ratio (LOD) score of 10.9.
Figure 2
The linkage result at chromosome 4 for all patients (in black) and
patients whose age at onset is greater than 16 y genotyped with a
1000 marker genome-wide microsatellite screening set revealing a
logarithm of odds ratio (LOD) score of 3.6.
Figure3
The linkage result at chromosome 5 for female psoriasis patients
genotyped with a 1000 marker genome-wide microsatellite screen-
ing set genotyped with a 1000 marker genome-wide microsatellite
screening set showing a logarithm of odds ratio (LOD) score of 2.6.
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on chromosome 4q at DGS106 (Fig 2), almost meeting
accepted criteria for genome-wide significance compared
with a modest score of 1.5 in the cohort as a whole, near a
region that has been linked to psoriasis families in the UK
(Matthews et al, 1996). Linkage has recently been reported
in Chinese Hans at D4S413 (Zhang et al, 2002), which maps
within 5 Mb of our linkage peak on 4q. We observed another
suggestive locus in the older onset group with an LOD score
of 3.1 on chromosome 14p (marker D14S261). The AOPP
group had an LOD score of 7.2 in the MHC despite the
previously stated relative deficit of patients carrying Cw6 in
patients with late disease onset compared with the early-
onset group.
Linkage analysis of the POPP group gave an LOD score
of 8.6 at the MHC. No other location approached genome-
wide significance in this group, except that a suggestive
LOD score of 2.5 is observed for maternal transmission on
6q at D6S1603 within 10 Mb of where Nair et al (1997) found
evidence for linkage.
Nail involvement We also analyzed 310 patients who had
one or more types of psoriatic nail lesions. They were clus-
tered at six meioses into 119 families and a linkage scan
revealed an LOD score of 6.0 in the MHC at marker TNFA. In
addition, when maternal transmissions were analyzed,
suggestive LOD scores of 2.6 were observed on 6q at
D6S1614, the same location as POPP and on 9p at D9S235,
and an LOD score of 2.7 on chromosome 11 at D11S4162.
Scalp onset Psoriasis of the scalp is a characteristic fea-
ture of sebo-psoriasis (van de Kerkhof and Franssen, 2001)
and has been reported as the most common site affected
by psoriasis as well as the most frequent site of disease
onset (Farber and Nall, 1992; Gudjonsson et al, 2002). Of
1000 patients, 296 (30%) reported that psoriasis began on
their scalp. Of these patients, 198 clustered into 79 families
and an LOD score of 3.4 was observed, at the q-telomeric
end of chromosome 10 (Fig 6). A similar score of 3.1 was
found closeby in males with scalp affection at D10S1700.
This position may coincide with a locus reported by Nair
et al (1997).
Koebner’s phenomenon Some psoriasis patients develop
psoriatic lesions at sites of trauma and this is referred to as
Koebner’s phenomenon. In our cohort, the ratio of female
patients to male patients with Koebner’s is 58%–42%. Of
398 patients who had experienced this reaction, it was
possible to cluster 259 into 98 families yielding an LOD
Figure 4
The linkage result of psoriasis patients who carry at least one Cw6 allele genotyped with a 1000 marker genome-wide microsatellite
screening set showing suggestive linkage on chromosomes 5 and 7.
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score of 4.8 in the MHC. Additionally, when female Ko-
ebner’s patients were designated as affected, a score
exceeding 3.1 was observed on chromosome 14q at
D14S1050 (Fig 6).
Psoriatic arthritis We have previously reported an LOD
score of 4.19 on the q-arm of chromosome 16 for paternal
transmission of psoriatic arthritis in 100 patients who clus-
tered into 39 families (Karason et al, 2003). Addition of
Figure 5
The linkage result of psoriasis patients who do not carry a Cw6 allele genotyped with a 1000 marker genome wide microsatellite screening
set showing modest linkage on chromosomes 1 and 17.
Figure 6
The linkage result on chromosome 10 of psoriasis patients
genotyped with a 1000 marker genome-wide microsatellite screen-
ing set whose psoriasis onset was on the scalp in red and
unstratified in black showing a logarithm of odds ratio (LOD) score
of 3.4.
Figure7
The linkage result on chromosome 16 of psoriatic arthritis patients
when the analysis was conditioned on paternal transmission
genotyped with a 1000 marker genome-wide microsatellite screen-
ing set with a score of 5.69.
PSORIASIS LINKAGE: SUBPHENOTYPES 1181124 : 6 JUNE 2005
markers to this region in order to increase information con-
tent increased the LOD score to 5.69 when analysis was
conditioned on paternal inheritance, providing further con-
firmation of the importance of this locus.
Discussion
In the course of analyzing subphenotypes in psoriasis,
we have replicated linkage to a number of loci found by
Table I. The entire cohort was genotyped using this set of 36 microsattelite markers in the MHC
Marker Primer forward Primer reverse
C78-32886-2 GGTCAGGTGTAATGGAATTTGA TTGCAGGTGATCTGCTTCTC
CA-RING3 TTTACAGATTCCCACCTCGG TAGGGAGACTACCGATCCCC
D6S1621 AAAGATTTAGAGTAAATGCTGATGA ACCACAGATGAGAATGCCTT
G-511525 GGTAAAATTCCTGACTGGCC GACAGCTCTTCTTAACCTGC
GATA61E03 CTGTATTAGTCGGGGTTCTCC GGTATTTTTTGCCACATGA
SA-99508 TGGAATCTCATCAAGGTCAGAA TTGATACTTTCCTAATTCTCCTCC
TNFC GCTTTCTCTGACTGCATCTTGTCC TCATGGGGAGAACCTGCAGAGAA
CA-JAP-119 CCTTAGCCCCTGTCCTTCAC AGGGAGGAGAGAAAAGTGGG
CA-MICB-1 GGCGTGCCATTTTGTATTTC TGAGAAGCTATGGGGGAG
D6S265 ACGTTCGTACCCATTAACTT ATCGAGGTAAACAGCAGAAA
D6S273 GCAACTTTTCTGTCAATCCA ACCAAACTTCAAATTTTCGG
D6S306 TTTACTTCTGTTGCCTTAATG TGAGAGTTTCAGTGAGCC
GATA4A03 CCTCCATAATTGTGTGAGCC CCAATCTTCTAACCCAAGCA
NOTCH-47 TCCACGTTGTGATCATCCAT GGGGCAGGTAAAAACATCCT
C2-AAAAT ACCCAGCTACTTGGGAGGAT CCTCGACGTGCAATGAGTA
CA-J-180 GAAGAAATCCTGCCTCAGAA TGTTCCTGTAGAACCACTCTTCG
CA-J-269 AGGGCCCAGTAGTAAGCCAG TGACTTCATATCCTGAAAGGG
D6S464 TGCTCCATTGCACTCC CTGATCACCCTCGATATTTTAC
GCT4BO5 GGGTCTGACCACTGAGACAC CAGTGAGAGCTCTGAGGGTC
C78-12480 CCAAGATCACCCTACCACAC TCAAGGAACCTGGAGGGAGAA
C78-57190 TGTTCACACCATAAACAAATGG GGTGAAAATCTACCTGTTGGC
D6S1558 GCTACTTGGGAGGCTGGAC CTGGCAGGAGGGCTAG
D6S2443 CCATACCAAAGTAAAACCCAG GAGGATGAAGGGAAATTAGAG
D6S258 GCAAATCAAGAATGTAATTCC CTTCCAATCCATAAGCATGG
HLAF AATTGCACTTGCCTCACG ATGCTTTGGTTGTTGCCACC
D6S306 TTTACTTCTGTTGCCTTAATG TGAGAGTTCAGTGAGCC
CA-DQBA GGGAAGGATTCTAAATAGGGGA CAGCATTCTGGAGGTGTGTG
D6S1683 CTGCACATGTATCCGAGAA TTTNAAGTAGAGACAGGATTTCTTG
M6S176 GAAAGTCTTGAAGTCAGGTGTGGC TGAGAGTTCAGTGAGCC
M6S178 TTGAACCAGGAGGTGGAGGTTG CAAGCATTCTGGAGGTGTGTG
M6S162 CGCTATTGCATTCCAGCCTG TCTAGTCATCCCTCCCTACTGCTG
M6S102 CCTAATCCAAAGGCATGGCTTC GGTGACAAAGCGAGACACCATC
M6S105 GGGTGCCACAAGAATTGCAG TCCAGCCTGTGATAGAGTGAGACC
M6S198 AGATCATGCCACTGCACTCCAG CTCAAGCCTGGGTGATAGAGAAAG
M6S161 TTGAACACAACCATCTCTGCTCC ATCAGCCTGCTTCTGGGATTCTCC
M6S224 AACTGTTCCTCTCTCTTAGAAGGCAGC ACCTGGGCAATACAGCAAGACC
Many of them were developed in-house and carry names unfamiliar to the reader. Many of them have likely found their way into the literature and carry
standardized names.
MHC, major histocompatibility molecules.
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other groups to be at least suggestive of linkage to psoria-
sis. In the past, an LOD score exceeding 2 in one cohort
at a location where another cohort has had a genome-wide
significant locus has been regarded as confirmation. Rep-
lication of the MHC locus has been almost universal (Capon
et al, 2002), but secondary loci in various populations
have been diverse, suggesting that HLA-C or some
gene very close to it is a major susceptibility allele. When
such observations are made in more than one population,
it becomes more likely that the mapped gene reflects
more than a population-specific trigger or modifying
effect and justifies the expenditure of resources on fine
mapping.
The presence of a suggestive locus with an LOD score of
2.5 at D16S205 at 84 cM from the p-telomere in addition to
the increased LOD score of the paternally inherited locus in
psoriatic arthritis patients increases our confidence that a
gene contributing to psoriasis and psoriatic arthritis is lo-
cated within that genomic region. Fine mapping efforts are
already reducing the size of the interval.
In general, our findings are consistent with the possibility
that a careful phenotypic classification may help to localize
genes that contribute to complex genetic diseases. Thus,
differences in phenotypic composition of study cohorts
might, in addition to variations between different popula-
tions, explain, at least in part, divergent findings reported by
individual study groups. It is interesting in this context that
the locus on 4q that we observed in Icelandic psoriasis
patients with adult onset has the same location as linkage
found in Chinese psoriasis patients. Although LOD scores
that we report here for various subphenotypes are not sta-
tistically significant even before accounting for multiple
testing of phenotype classes, this approach provides a way
to: (1) predict the relative contribution of a given locus to
specific or general phenotypes of psoriasis, and (2) alter the
follow-up collection strategy to focus limited resources to
increase the number of patients whose subphenotypes map
to particular loci. That is, guided by early linkage analysis of
large cohort, the future strategy on a particular population
could become focused to increase the likelihood of a sta-
tistically significant linkage and ultimate isolation of at least
one psoriasis gene. Further analysis of psoriasis subphe-
notypes may therefore be an effective strategy for localizing
and identifying genes that predispose to psoriasis and such
an approach has also been successful in other complex
diseases including fine mapping of autistic disorders (Shao
et al, 2003).
In order to stratify patients according to phenotypic cri-
teria, there are two major prerequisites. First, the patient
population must be large enough so that dividing the pop-
ulation in half or thirds does not decrease the power below a
threshold for mapping genes. Second, systematic collection
of phenotypic traits used for stratification must be carried
out on at least 90% of the cohort so that power does not
suffer because of incompleteness of data and to decrease
the possibility of bias. In our psoriasis study, we began with
one of the largest cohorts on psoriasis ever collected and
we strived for close to complete ascertainment of clinical
information (our phenotype data set was 95%–100% com-
plete). In addition, the ability to recreate large extended
families using a computerized genealogy database (rather
than maintaining the original pedigrees, many of which will
fall out when only one patient remains within each pedigree)
increases the number of families available for the study of
each subphenotype, further increasing power for mapping
psoriasis genes.
It is concluded that a careful characterization of sub-
phenotyes may greatly help to analyze complex genetic
diseases.
Materials and Methods
The National Bioethics Committee of Iceland and Data Protection
Authority (DPA) of Iceland approved this study and informed con-
sent was obtained from all participants. We used our comprehen-
sive Icelandic genealogical database (Gulcher and Stefansson,
1998) to automatically derive families that included patients sep-
arated up to and including seven meioses (six meioses separate
second-cousins). All personal identifiers associated with medical
information and blood samples as well as the Icelandic genealog-
ical database were reversibly encrypted by the DPA (Gulcher et al,
2000).
Patients and phenotypic documentation Altogether, over 3000
individuals were evaluated and 1000 patients with definite psoria-
sis identified. The majority of participants in this study had at least
one first- or second-degree relative affected by psoriasis, and were
recruited by the Icelandic Psoriasis Association (SPOEX). As pre-
viously described (Gudjonsson et al, 2002), patients were evalu-
ated by either of the two physicians (J. E. G., H. V.). A detailed
clinical history was obtained by a structured questionnaire, and a
careful physical examination was also carried out and the local-
ization, distribution, and the size of the lesions were recorded. The
patients had to have at least one unequivocal psoriatic plaque at
the time of examination to be included as affected. Information
recorded for each patient included age, site, and mode of onset,
disease severity, Koebner’s phenomenon, nail lesions, arthritis, and
the effects of a variety of environmental factors. Nail changes were
only recorded for the fingers, because of a high frequency of fungal
infections in toenails (Gudnadottir et al, 1999) that can mimic
psoriatic nail lesions. Patients with seborrheic or pustular psoriasis
or a history of guttate psoriasis were only included if they had
typical chronic psoriatic plaques at the time of examination. We
were able to connect a number of families using our computerized
geneology database (Gulcher and Stefansson, 1998), and ended
up with 238 extended pedigrees. Approximately 505 Icelandic
controls were genotyped in order to ascertain control allelic fre-
quency for all markers in the Icelandic population.
Genotyping and analysis of linkage Participants were geno-
typed using a 1000 marker fluorescently labelled microsatellite
screening set with an average density of 3 cM, where genetic lo-
cations are based on the deCode map (Kong et al, 2002). Addi-
tional markers were genotyped for regions showing the strongest
evidence for linkage, increasing the density up to 1 cM. Genotyp-
ing was performed under standard conditions (Gretarsdottir et al,
2002). HLA-B and HLA-C were typed using Dynal SSP (Dynal
Biotech, Oslo, Norway) typing kits under standard protocol conditions.
All reported LOD scores were calculated with Allegro (Gudbj-
artsson et al, 2000). Allegro computes non-parametric, multipoint,
affected only, allele-sharing LOD scores based on the S-pairs
scoring function (Kruglyak et al, 1996), and an exponential allele-
sharing model (Kong and Cox, 1997). It should be noted that the
published deCode genetic map was constructed based on the
Haldane map function, or a no-interference model, but distances
were converted to Kosambi distances to make them directly com-
parable with the Marshfield map (Broman et al, 1998). But Allegro,
like many other multipoint linkage programs, can only process a
no-interference model. Hence, calculations here were based on
PSORIASIS LINKAGE: SUBPHENOTYPES 1183124 : 6 JUNE 2005
the originally estimated Haldane map. Positions of markers not in
the deCode map were determined by interpolation based on phys-
ical distances.
Families were weighted halfway on the log scale between
weighting families equally and weighting all pairs of affected
equally. This scheme gives similar weights as those proposed by
Weeks and Lange (1988) as an extension of the scheme Hodge
(1984) designed for sibships, and we have used as the default (see
for example Gretarsdottir et al, 2002). Exact p-values were calcu-
lated by comparing the observed LOD score with its complete data
sampling distribution under the null hypothesis (Gudbjartsson et al,
2000), where linkage results are considered significant if the single
test p-value is below 2  105 (Lander and Kruglyak, 1995).
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